Co.Don

Co.Don AG is a biopharmaceutical company and also a biotech company in Germany dedicated to the research, development, production, and sales of tissue engineering and regenerative medicine products. Its core product, Spherox, is the only cell therapy product officially approved in Europe (including the EU, UK, Switzerland, and other countries) for articular cartilage repair and regeneration. It is also one of only two products globally to have received formal market approval from European and American regulatory authorities for cartilage repair and regeneration, alongside MACIÒ, the flagship product of American Vericel Corporation (NASDAQ: VCEL). To date, Spherox has successfully treated more than 17,000 patients with severe articular cartilage defects in Europe, and its safety and efficacy have been fully validated.